Alcohol and CNS depressants may cause additive CNS depressant effects when used concomittantly.

Short acting hypnotic in management of insomnia

Rare-Thrombocytopenia, purpura, drug idiosyncrasy with fever. Paradoxical  excitement in
children, mild GI symptoms, skin rashes.
 

Hypersensitivity

Special precautions:
Hazardous tasks- observe caution
 

Indications:
Short acting hypnotic in management of insomnia

Dosage:
500 to 1000mg taken 20min before bedtime
 

1. May cause drowsiness or dizziness, observe caution while driving or performing other tasks
   requiring alertness.
2. Avoid alcohol and other CNS depressants. Do not exceed prescribed dosage.

Pharmacology:
Ethnamate is a hypnotic agent and a nonselective CNS depressant

Pharmacokinetics:
Rapidly absorbed from GI tract, partially inactivated in the liver and excreted in the urine .
Following a 1g dose peak plasma levels are reached in about 36 minutes and decline to a
negligible value over 8 hours. Elimination half-life is 2.5 hours. Approximately 36% of the dose
appears in the urine within 24 hours
 

Reports not available

Pregnancy:
Give only if clearly needed.

Lactation:
Use with caution while administering to a nursing mother.

Children:
Safety  and efficacy for use in children below 15 years are not established.